Psychiatrist testifies she has no regrets over treatment of Diego Maradona
Psychiatrist Agustina Cosachov, one of the seven healthcare professionals on trial accused of negligence in the death of Diego Maradona, testified she does not regret the treatment she provided to the football great.
She blamed the private medical company for the deficiencies in his home care.
Maradona had surgery for a haematoma which formed between his skull and brain and stayed in intensive care at Los Olivos clinic between November 4 and 11 2020.
He was sent to recover to a private home where he died on November 25 at the age of 60.
'I acted convinced that what I was doing was best for the patient,' said the psychiatrist on Thursday, the first of the defendants to testify in the courts of San Isidro, a northern suburb of Buenos Aires. 'In my role, I did what I could and even more.'
Cosachov was part of Maradona's medical team during the final stages of his life, along with neurosurgeon Leopoldo Luque and psychologist Carlos Diaz.
The three are on trial with doctors Nancy Forlini and Pedro Di Spagna, Mariano Perroni, a representative of the company that provided the nursing service, and nurse Ricardo Almiron.
Maradona died in a rented house in Tigre, a northern suburb of Buenos Aires.
Cosachov broke down in tears twice during her testimony, once when the presiding judge asked her what she thought happened to Maradona, to which she responded simply: 'I don't know'.
Three judges will decide whether those charged are guilty of manslaughter. The maximum jail time for those sentenced is 25 years.
According to the prosecution, the accused professionals did not provide adequate medical care.
'We were all in agreement for home hospitalisation,' the psychiatrist stated, referring to Maradona's daughters, his sisters, his ex-wife, and the company's doctors.
'Involuntary hospitalisation was also considered, but the family didn't want that, and home hospitalisation was the only option.'
According to the testimony of the director of the clinic where Maradona had surgery, the soccer star requested alcohol during the post-operative period, and was difficult to deal with.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
18 hours ago
- Business Wire
Foldax Announces Positive One-Year Data on TRIA Mitral Valve
SALT LAKE CITY--(BUSINESS WIRE)--Foldax® Inc., a leader in the development of innovative polymer heart valves, today announced compelling one-year results from the India Clinical Trial of the TRIA™ Mitral Valve, showing a good safety profile, sustained hemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicenter clinical study of a polymer heart valve worldwide. Results were presented today at New York Valves 2025, the annual conference organized by the Cardiovascular Research Foundation (CRF), and concurrently published in the Journal of the American College of Cardiology (JACC). 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve.' Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. Share Key one-year results from the trial showed: No valve-related mortality or reinterventions >50% reduction in mean gradient (9.7 mmHg to 4.5 mmHg) and >90% increase in effective orifice area (0.9 cm² to 1.5 cm²), the highest reported in similar surgical mitral valve studies 24-point improvement in KCCQ score (57.5 to 81.9) and 65% increase in Six-Minute Walk Test distance (298.1 m to 494.8 m), indicating significant improvement in quality of life The prospective, multicenter trial enrolled 67 patients aged 19 to 67 across eight sites in India, with an average age of 42. Notably, 64% were women, and of these, nearly half were of childbearing age, a significantly larger percentage than typically seen in clinical studies. Seventy-three percent of patients had rheumatic heart disease. 'It is exciting to see the positive clinical outcomes associated with this novel polymer valve,' said Isaac George, M.D., Surgical Director of the Heart Valve Center at Columbia University. 'This new type of valve sets out to reimagine how a device can address clinical needs that are underserved by current valve solutions.' 'I am proud to be the principal investigator in India for this groundbreaking trial and represent the highly esteemed clinical investigators who participated in the study,' said Kaushal Pandey, M.D., Principal Investigator of the TRIA Mitral Valve India Clinical Trial and Cardiac Surgeon at P.D. Hinduja Hospital in Mumbai. 'The TRIA Mitral Valve provides hope for Indian patients—including younger patients and many women of childbearing age—for whom current valve options often fall short.' Foldax's vision for its novel polymer heart valves is to address the limitations of tissue and mechanical options by making its valves durable, with the future goal of avoiding a requirement for lifelong anticoagulation. TRIA valves incorporate a proprietary polymer—LifePolymer™ —formulated to be calcium-resistant, biostable and biocompatible. The novel polymer material enables TRIA valves to be robotically produced, which is designed to increase manufacturing efficiency and maximize product quality and precision. 'These results validate our strategy of taking heart valve therapy to a new level by bringing innovation to a platform of products that will help patients globally,' said Ken Charhut, CEO of Foldax. The Journal of the American College of Cardiology (JACC) publication can be viewed at: *The TRIA Mitral Valve is approved for use in India by CDSCO. The TRIA Mitral Valve is for investigational use only and is not available for commercial sale in the U.S. Headquartered in Salt Lake City, Utah, Foldax is reinventing every aspect of the heart valve—from material to design to manufacturing—to develop surgical and transcatheter valves with the potential to last a lifetime, addressing limitations of tissue and mechanical valves. Foldax investors include Angel Physicians Fund, Biostar Capital, Caltech, Glenview Capital, Kairos Ventures, Memorial Care Innovation Fund and Sayan Bioventures. For more information on the TRIA Mitral Valve and Foldax's commitment to revolutionizing heart valve care, visit
Yahoo
5 days ago
- Yahoo
Newborn died within hours after doctor used ‘vacuum-assisted' delivery method, his ‘permanently wounded' parents claim
A newborn suffered a 'short life and prolonged death' – within hours of his birth – after a Texas doctor attempted a vacuum-assisted delivery, according to a lawsuit. The lawsuit, filed May 29 against the doctor, unnamed nurses, Kessler Women's Healthcare and the Methodist Dallas Medical Center, claims they were negligent in trying to deliver the child vaginally in April 2024, The Fort Worth Star-Telegram reported. According to the suit, the boy, who was named Prime, died of internal brain bleeding caused by his delivery method, but may have lived if the doctor had performed a Cesarean section earlier, instead of attempting to deliver him via vacuum-assisted delivery. The baby's parents, both teachers, headed to the hospital on April 4, 2024, when the 32-year-old mother's water broke, according to the lawsuit. According to the lawsuit, the doctor the family had been seeing was not the one to deliver the baby. While preparing to give birth, Prime's heart rate became abnormal and his mom was diagnosed with preeclampsia, a dangerous complication characterized by high blood pressure. She also had a 102.9 fever, according to the filing. These risk factors, in addition to the baby's large head size and weight, meant the mother would likely have to receive a Cesarean section, the lawsuit claims. However, instead of delivering the baby via C-section, the doctor decided to try vacuum-assisted delivery for a vaginal birth. The process involves using a suction-cup device that attaches to the baby's head to try and help the child down the birth canal, according to the lawsuit. The doctor on call tried to deliver Prime four times, but the suction popped off twice, the family said. The father 'recounted the very 'loud sound' produced by the pop-offs and noted that the force was so significant that it caused (the doctor) to push the chair backwards in the delivery room, suggesting that (she) exerted considerable force during the pulls,' the lawsuit says. Once the newborn was delivered, he was taken to the neonatal intensive care unit. When the mom saw what her son's neck looked like post-birth, 'she wanted to burst into tears,' the filing claims. Prime 'suffered' for 24 hours before he died, according to the filing, which described those hours as a 'short life and prolonged death.' The lawsuit claims the OB-GYN told the family their baby died from an E. coli infection he caught during labor. However, the doctor who conducted the autopsy found his real cause of death was brain hemorrhages from failed vacuum-assisted delivery. 'Permanently wounded, the couple for days, weeks and months have broken down and cried, often uncontrollably,' the lawsuit says. 'Prime's loss has haunted them with nightmares, sleeplessness and intrusive thoughts. Daily life was permanently altered for both, though, they will try to move forward.' Another doctor who was conducting an independent review told the parents Prime may have been born 'healthy and whole' had a C-section been performed sooner, according to the filing. The lawsuit blames the doctor and nurses for not recognizing the baby's distress during labor and taking the appropriate steps sooner. The family also claims in the suit that the doctor never told them of the risks of vacuum-assisted delivery. The couple is seeking damages, claiming negligence, lack of informed consent and their son's wrongful death, according to the report. Methodist Health System said in a statement that it has a 'longstanding policy of not commenting on pending litigation.' The doctor involved told The Dallas Morning News that she couldn't comment on specific patients, but said, 'I will simply say that I am committed to providing the highest quality medical care possible to my patients.'
Yahoo
19-06-2025
- Yahoo
Fears as 'no medical record exists of examination' that led to fatal discharge of little girl
A coroner has written to Wes Streeting over the tragedy of little Lila Marsland, who was found dead from meningitis, hours after being sent home from hospital being told she had tonsillitis. The coroner told Mr Streeting that he is 'concerned' about how 'vital clinical information' could risk 'being lost' in a complicated 'mixture of various analogue and digital systems' in use at Tameside General Hospital. Alarm around missing medical information include that 'no medical record appears to exist of the examination of Lila which was undertaken by the locum registrar in paediatrics which resulted was discharged from hospital'. READ MORE: Hay fever or Covid? How to tell the difference as new Nimbus variant hits UK READ MORE: How to tell if you have new 'Nimbus' Covid variant or summer cold The coroner also aired fears for the rest of the country's hospitals which 'continue to operate with information being stored and shared in a fragmented and disjointed way'. Lila Marsland was found unresponsive in bed by her mum, dying from meningitis. But around eight hours earlier, the five-year-old was discharged from a long stint in Tameside Hospital as her mum was told she had tonsillitis. Following an inquest at the start of June, which examined Lila's care and treatment at Tameside General Hospital, a jury concluded her death was preventable and 'contributed to by neglect'. Coroner Chris Morris told the Secretary of State for Health and Social Care: 'The court heard evidence that, over the course of almost 10 hours in hospital, Lila's history and details of examinations and assessments undertaken were recorded on a mixture of various analogue and digital systems in operation in different parts of the Trust, leading to a risk of vital clinical information being lost in the system. 'I am concerned that this, and other hospitals elsewhere in the country, continue to operate with information being stored and shared between professionals in a fragmented and disjointed way.' On December 27, 2023, Lila started getting sick. By the evening, Lila's mum - a district nurse who worked for Tameside and Glossop Integrated Care NHS Foundation Trust - knew it was serious enough to take her daughter to the trust's A&E at Tameside Hospital. Lila was suffering headaches, a sore throat, a high heart rate, neck pain and limited neck movement, vomiting, lethargy and was unable to pass urine. Lila was sent from adult A&E to paediatric A&E. Mum Rachel Micherton asked hospital staff if it was meningitis. A number of nurses were concerned meningitis was a possible cause for Lila's illness but, following tests and a review by an experienced paediatric registrar doctor, decided she was more likely suffering from tonsillitis. The five-year-old was discharged from Tameside Hospital with antibiotics and a throat spray at around 2am on December 28. Around eight hours later, she was found unresponsive in bed by her mum. She called 999 and attempted CPR. Paramedics arrived, but Lila was pronounced dead at 9.19am. Following the inquest last month at Stockport Coroners Court, the Greater Manchester South Area Coroner produced two 'prevention of future deaths' reports. The reports are sent to relevant authorities to attempt to stop further deaths from causes uncovered during an inquest. Along with his letter to Mr Streeting, the coroner also wrote to the bosses of Tameside and Glossop Integrated Care NHS Foundation Trust raising fears about its lacking implementation of the National Institute for Health and Care Excellence (NICE) guidance around meningitis, and notes missing from Lila's case. The absent notes include a record of the final review of Lila by a senior paediatric registrar before she was fatefully discharged. The coroner's prevention report aimed at trust bosses reads: 'I am concerned that no medical record appears to exist of the examination of Lila which was undertaken by the locum registrar in paediatrics which resulted was discharged from hospital. 'The absence of this key piece of evidence serves to limit the ability of the trust to derive all possible learning from Lila's death.' The coroner also shared fears that crucial childhood sepsis screening tools are 'not yet fully embedded in the minds of those who assess and treat children and young people at the trust'. Mr Morris, too, aired concerns that an emergency medicine consultant who approved Lila's transfer from adult to paediatric A&E 'provided a statement to this court that they had seen' Lila 'and 'visually assessed [her] at least'. When called to give evidence in court during the inquest, the consultant admitted this had not happened. Earlier in the inquest, the hearing was told that in a supplementary written statement to the inquest, Dr Muhammad Farooq said: "In this case, on the request of the staff nurse, I performed a preliminary visual assessment and reviewed the patient's vital signs." However, speaking in the witness box, he said he now accepted that was 'wrong' and he had not 'eyeballed the patient'. "Do you accept, in this case, those words are misleading?," Mr Morris said. "It implies you had been to see Lila, or seen her from a distance." "I accept a mistake," Dr Farooq said. "I very openly and honestly accept the mistake." "Should you have gone to see Lila?" Mr Morris asked. "If I would have gone to see Lila, in my final assessment I would have transferred the patient in the same manner, to the paediatric emergency department, to get her seen quickly," he said. Asked how he knew that, Dr Farooq said: "The department was very busy and there was no space downstairs to see the patient. That was the quickest way to see the patient." Ms Mincherton has not returned to work since Lila's death and was 'uncertain' about doing so, as she would 'need to promote the trust' that dealt with her child. More than a year on, an inquest determined Lila died from pneumococcal meningitis streptococcal pneumonia. The Hyde girl's death from meningitis was 'contributed to by neglect', the jury concluded after an eight-day inquest. 'Had Lila been admitted to hospital and given broad spectrum antibiotics within the first hour of being triaged, this would have prevented Lila's death,' the jury concluded. The trust has apologised and accepted there were failings. Ms Mincherton, outside court, said: "I would like to thank the jury for coming to this conclusion, based on the evidence provided - a conclusion I have known for 17 months. "Hearing the word 'neglect' is something a parent should never have to hear and we are now left with the devastating loss of our daughter for the rest of our lives." Rachael and scaffolder Darren, 42, said their lives - and that of Lila's 15 year-old sister Ava - had been 'devastated'. They have been left feeling 'empty'. A spokesperson for Tameside and Glossop Integrated Care NHS Foundation Trust said: "We want to express our sincere condolences to Lila's family for their heartbreaking loss. "It is clear from the independent investigation that there were missed opportunities in Lila's care. We accept the coroner's findings and apologise unreservedly for this. As a Trust, we have made and will continue to make improvements to ensure we learn from this case."
